Stanford School of Medicine
Cardiovascular Medicine In the Department of Medicine

Special thanks
to:

Merck & Co.,
Guidant, and
Bristol-Myers Squibb

for their unrestricted support of this website.

A World Leader

Stanford Interventional Cardiology is a world leader in percutaneous coronary revascularization. We perform over 1000 interventions per year and offer the latest breakthroughs in the treatment of  coronary artery disease and valvular heart disease.

Our site will be updated regularly and parts of it are currently under construction. We apologize for any inconvenience this may cause. Feel free to give us feedback on our site and let us know what topics you would like to see.

What's new

Drug-eluting Sent Conference at Stanford
Saturday, January 18  8 am - noon
)
Thanks to everyone for supporting the program.

 

We are offering new services including ASD and PFO closures and alcohol septal ablation for hypertrophic cardiomyopathy. Call us for details!

 

Clinical Trials Update! New and ongoing clinical trials with novel embolic protection devices, etc.....

 

 

 

 

 

Institution Links:

Footer Links: